These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1689845)

  • 1. [Role of B-CD5 lymphocytes in the physiopathology of autoimmune diseases].
    Youinou P; Lydyard P
    Presse Med; 1990 Feb; 19(5):199-200. PubMed ID: 1689845
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of CD5-positive B cells in nonorgan-specific autoimmune diseases.
    Youinou P; Mackenzie L; Broker BM; Isenberg DI; Drogou-Lelong A; Gentric A; Lydyard PM
    Scand J Rheumatol Suppl; 1988; 76():243-9. PubMed ID: 2471999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5 positive B lymphocytes: a link between autoimmunity and B-cell oncogenesis.
    Bataille R; Klein B
    Anticancer Res; 1988; 8(4):707-10. PubMed ID: 2460021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes.
    Casali P; Notkins AL
    Annu Rev Immunol; 1989; 7():513-35. PubMed ID: 2469441
    [No Abstract]   [Full Text] [Related]  

  • 5. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce.
    Burastero SE; Casali P
    Contrib Microbiol Immunol; 1989; 11():231-62. PubMed ID: 2479500
    [No Abstract]   [Full Text] [Related]  

  • 7. Feedback suppression of normal and leukemic B cell colony growth by CD5+ B cells.
    Fernandez LA; MacSween JM; Robson DA
    Ann N Y Acad Sci; 1991; 628():379-81. PubMed ID: 1712559
    [No Abstract]   [Full Text] [Related]  

  • 8. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 9. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.
    Van de Velde H; von Hoegen I; Luo W; Parnes JR; Thielemans K
    Nature; 1991 Jun; 351(6328):662-5. PubMed ID: 1711157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
    Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
    Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal B cell compartment in chronic lymphatic leukemia.
    Pluta A; Górski A; Nowaczyk M; Modlińska M
    Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface antigen CD5 is a marker for activated human B cells.
    Werner-Favre C; Vischer TL; Wohlwend D; Zubler RH
    Eur J Immunol; 1989 Jul; 19(7):1209-13. PubMed ID: 2474446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of CDS+ of B-lymphocytes in the physiopathology of the hematopoietic system].
    Pluta A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):148-50. PubMed ID: 1279643
    [No Abstract]   [Full Text] [Related]  

  • 14. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.
    Casali P; Notkins AL
    Immunol Today; 1989 Nov; 10(11):364-8. PubMed ID: 2482031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
    Youinou P; Pers JO; Jamin C; Lydyard PM
    Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL).
    Shirai T
    Tohoku J Exp Med; 1994 May; 173(1):133-40. PubMed ID: 7528945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors predisposing to B-CLL and to autoimmune disease in spontaneous murine model.
    Hirose S; Hamano Y; Shirai T
    Leukemia; 1997 Apr; 11 Suppl 3():267-70. PubMed ID: 9209361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [At the crossroads between B lymphoproliferative syndromes to autoimmune diseases are CD5-positive B-lymphocytes: a new hypothesis].
    Youinou P
    Bull Acad Natl Med; 1999; 183(1):159-69; discussion 170. PubMed ID: 10371774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Szegedi G
    Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.